The company has received approval from the US Food and Drug Administration (USFDA) to market its product which is a generic version of Hikma Pharmaceuticals USA Inc product, Alembic Pharmaceuticals said in a statement.from Moneycontrol Business News https://ift.tt/fhxUNL0
No comments:
Post a Comment